ALGT vs GILD · rev $943.5M vs P/E 18, rev $7.80B
Allegiant Travel Company (ALGT) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Allegiant Travel Company (ALGT) is a airlines company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Latest reported ALGT revenue for 2026-06-30 was $943.5M. Net income was -$4.9M. Revenue was up 28.8% from 2026-03-31 to 2026-06-30. ALGT currently screens at market cap $1.02B.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
ALGT currently screens at market cap $1.02B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the ALGT and GILD stock pages for the full models.
Not investment advice.